Phase 2Not yet recruitingNCT07430332
GLP-1 receptor agonist for stage-1 T1D
Stage-1 T1D trial testing a GLP-1 receptor agonist as an early intervention before clinical diabetes.
Primary endpoints
- C-peptide area under the curve
- C-peptide area under the curve (AUC)
Results so far
No results posted yet.